Latest Prescription Drugs news
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
posted September 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
posted September 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
posted September 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine
posted September 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
